Why Full Disclosure Matters Before Starting Ketamine
Ketamine troche therapy requires a thorough medical and psychiatric evaluation before a prescription is appropriate. This evaluation exists to protect you — not as a bureaucratic hurdle. Ketamine has meaningful cardiovascular effects, interacts with numerous medications, and is contraindicated in several medical and psychiatric conditions. A provider who doesn't ask detailed questions before prescribing is not providing adequate care.
This article walks through everything you should disclose to your prescribing provider before starting ketamine troches, organized by category. Bring this information in writing to your evaluation appointment; it will make the conversation more complete and efficient.
Psychiatric History
Current Mental Health Conditions
Your provider needs to know exactly what you're being treated for and the severity of your current symptoms. Be specific:
- Diagnosis (if you have one) and how it was established
- Duration of your current episode or symptom burden
- Functional impact: how does your condition affect work, relationships, and daily activities?
- Current symptom severity (provide scores if you've completed PHQ-9, GAD-7, or similar instruments)
Previous Treatment History
Detail all previous mental health treatments:
- Antidepressants previously tried: drug name, dose, duration, reason discontinued
- Augmentation strategies tried (lithium, atypical antipsychotics, thyroid hormone)
- Previous psychotherapy: type, duration, and whether it was helpful
- Previous ketamine treatment: IV, IM, nasal, or troche; doses; response; why discontinued
- Electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS): response and dates
For patients seeking ketamine for treatment-resistant depression, documentation of prior treatment failures is typically required to establish medical necessity.
Psychiatric Diagnoses to Disclose
Certain diagnoses significantly affect whether and how ketamine can be safely prescribed:
- Schizophrenia or schizoaffective disorder: Ketamine is generally contraindicated due to the risk of exacerbating psychotic symptoms. Disclose any history of psychosis.
- Bipolar disorder: Ketamine can precipitate manic episodes. Providers often proceed with caution, mood stabilizer coverage, and enhanced monitoring. See our article on ketamine and bipolar disorder for details.
- Active substance use disorder: Active addiction to any substance (alcohol, opioids, stimulants, etc.) affects prescribing decisions. Honesty here is essential.
- Personality disorders: Borderline personality disorder and other personality disorders may require modified protocols and integration support.
- Dissociative disorders: Prior history of dissociative identity disorder or depersonalization may affect tolerability and protocol.
Suicidal Ideation and History
Disclose any history of suicidal ideation, suicide attempts, or self-harm. This is not disqualifying — ketamine is actually used therapeutically for suicidal ideation in some protocols — but it is critical clinical information that affects monitoring and the safety structure of treatment.
Medical History
Cardiovascular Conditions
Ketamine increases heart rate and blood pressure transiently during sessions. This is manageable for most patients but requires caution or contraindication in some:
- Hypertension: Disclose blood pressure history and current control status. Uncontrolled hypertension (consistently above 150/100 mmHg) may be a contraindication.
- Heart disease: Coronary artery disease, heart failure, arrhythmias, recent heart attack.
- Stroke history: Including TIA (transient ischemic attack).
- Aneurysm: Intracranial or aortic aneurysms are potential contraindications due to blood pressure effects.
Neurological Conditions
- Seizure disorder: Ketamine may lower seizure threshold in some contexts. Disclose any seizure history.
- Elevated intracranial pressure: A historical contraindication to ketamine; disclose any conditions that might increase ICP (tumors, hydrocephalus, significant head trauma).
- Traumatic brain injury: History and severity.
Other Medical Conditions
- Thyroid disease: Particularly hyperthyroidism, which combined with ketamine's sympathomimetic effects can amplify cardiovascular responses.
- Liver disease: Ketamine is metabolized hepatically; liver disease affects drug clearance.
- Glaucoma: Ketamine increases intraocular pressure; disclose if you have open- or closed-angle glaucoma.
- Urinary tract conditions: Chronic ketamine use has been associated with ketamine cystitis. Disclose any pre-existing bladder or urinary conditions.
- Respiratory conditions: Severe respiratory disease; though ketamine generally preserves respiratory function, disclose any relevant history.
Allergies and Previous Drug Reactions
List all known drug allergies and adverse reactions, including:
- Drug names and the specific reaction
- Reactions to anesthetics (relevant because ketamine is an anesthetic agent)
- Sensitivity to PEG or other potential troche excipients
Current Medications
This is one of the most critical disclosures. Provide a complete list of all medications, including:
Prescription Medications
- Drug name, dose, and prescribing provider
- How long you've been taking each medication
- Whether you take them consistently (adherence)
Pay particular attention to:
MAOIs (monoamine oxidase inhibitors): Phenelzine, tranylcypromine, isocarboxazid, and selegiline at high doses interact dangerously with many drugs. A ketamine prescriber must know if you're on an MAOI.
CNS depressants: Benzodiazepines, opioids, barbiturates, and sleep aids can increase sedation with ketamine. Disclose all of these.
Stimulants: Amphetamines and methylphenidate can interact with ketamine's cardiovascular effects.
Antipsychotics: These may blunt ketamine's dissociative effects and affect the therapeutic response.
Mood stabilizers: Lithium, valproate, lamotrigine — relevant to dosing and monitoring for patients with mood disorders.
Blood pressure medications: Help your provider understand your cardiovascular baseline.
Over-the-Counter Medications and Supplements
Do not omit:
- NSAIDs (ibuprofen, naproxen): Discuss frequency and indications
- Sleep aids (diphenhydramine, melatonin)
- Herbal supplements: St. John's Wort interacts with numerous drugs; valerian, kava, and others have CNS effects
- High-dose vitamins or mineral supplements
Substance Use
Be honest. Providers are asking to keep you safe, not to report you:
- Alcohol: How much, how often?
- Cannabis: Frequency and whether smoked, vaped, or edible (bioavailability and timing implications)
- Recreational or non-prescribed drugs: Type, frequency, last use
Pregnancy and Reproductive Status
Ketamine is not recommended during pregnancy. Inform your provider if:
- You are pregnant or possibly pregnant
- You are planning to become pregnant
- You are breastfeeding (ketamine enters breast milk)
Reliable contraception discussions should occur if you are of reproductive age.
Family History
Disclose relevant family psychiatric history:
- First-degree relatives with schizophrenia, bipolar disorder, or psychosis
- Family history of substance use disorders
- Family history of adverse reactions to anesthetics
What Happens With This Information?
Your provider will review all of this to:
- Determine whether ketamine troches are appropriate for you
- Identify any contraindications or conditions requiring modified protocols
- Adjust starting dose based on risk factors (conservative with cardiovascular conditions, older age)
- Establish appropriate monitoring parameters
- Provide informed consent documentation covering the specific risks relevant to your situation
A thorough intake evaluation protects both you and your provider. If a provider offers to prescribe without asking about your medical history, medications, and psychiatric background — that's a significant red flag.
Key Takeaways
- Disclose your complete psychiatric history, including diagnoses, previous treatment trials, and history of suicidality.
- Disclose all medical conditions, particularly cardiovascular, neurological, hepatic, and urological.
- Provide a complete current medication list — prescription, OTC, and supplements.
- Be honest about substance use. This is clinical information, not a judgment.
- Disclose pregnancy, breastfeeding, or pregnancy planning.
- A thorough intake evaluation is a sign of quality care, not bureaucratic excess.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
- WHO: Depression Fact Sheet — World Health Organization global data on depression prevalence, burden, and treatment approaches
Share